Your session is about to expire
← Back to Search
Nitric Oxide for Acute Kidney Injury (MGHK23 Trial)
MGHK23 Trial Summary
This trial will test whether nitric oxide, given through a mask, can improve outcomes for patients with kidney injury undergoing cardiac surgery.
MGHK23 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMGHK23 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MGHK23 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have recently undergone a planned heart or aorta surgery that lasted more than 90 minutes with the use of a heart-lung machine.You have signs of blood vessel problems as shown by a special questionnaire.
- Group 1: Control
- Group 2: Nitric Oxide
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the possible negative side effects of Nitric Oxide?
"There is pre-existing clinical evidence to support Nitric Oxide's safety, thus it was given a score of 3."
What is the size of the test group for this research?
"This particular study is no longer recruiting patients. The trial was initially posted on February 8th, 2017 and was last edited on November 8th, 2022. There are presently 131 clinical trials actively searching for patients with acute kidney injury and 24 trials for Nitric Oxide actively recruiting participants."
Does a body of research exist for Nitric Oxide's therapeutic effect?
"There are 24 ongoing clinical trials researching the efficacy of nitric oxide. 9 of these studies have progressed to Phase 3 testing. Although many of the investigations are based in Anchorage, Alaska, there are 116 locations across the world running similar trials."
Are new participants being sought for this research project?
"This study is not enrolling patients at the moment, however this could change in the future. The trial was originally posted on 2/8/2017 and was last updated on 11/8/2022. For those interested, there are presently 131 trials actively admitting patients with acute kidney injury and 24 studies for Nitric Oxide actively enrolling patients."
Share this study with friends
Copy Link
Messenger